Drugs / [89Zr]Zr-DFO-Diranersen
[89Zr]Zr-DFO-Diranersen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06454721 | Jan 2025 → Mar 2026 | — | Biogen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [89Zr]Zr-DFO-Diranersen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06454721 ↗ |
| Modality | Diagnostic / imaging agent | “positron emission tomography (PET) scanner that can detect radiolabeled diranersen” NCT06454721 ↗ |
| Route | Intrathecal | “via an intrathecal (IT) injection” NCT06454721 ↗ |